Drawing for DEMENTIA DISCOVERY FUND

USPTO serial 79207107

DEMENTIA DISCOVERY FUND

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
PEREZ, STEVEN M
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DEMENTIA DISCOVERY FUND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical preparations and substances for the prevention and treatment of dementia; sanitary preparations for medical purposes; pharmaceutical preparations, all for use in the treatment or prevention of brain diseases and degenerative dementia disorders; antiseptic preparations; prescription pharmaceuticals for humans for the prevention and treatment of dementia; veterinary and sanitary products, namely, antibiotics; dietary food supplements; health food supplements; vitamins; dietetic substances adapted for medical use, namely, sugar substitutes; food for babies; foods for medical purposes, namely, food for enteral feeding for teens adults and elders; homeopathic pharmaceuticals for use in the treatment of dementia; medicinal drinks; anti-diabetic drugs; hypertension medications; steroid hormones; non-steroidal anti-inflammatory drugs; chemicals in the nature of medical diagnostic reagents for use in medical and veterinary diagnosis of dementia disordersACTIVE—
036Insurance, namely, insurance brokerage; financial affairs, namely, financial information, management and analysis services; monetary affairs, namely, monetary exchange and monetary strategic consultation and research; real estate affairs, namely, leasing of real estate, real estate brokerage and real estate appraisal services; financing services in relation to medical research; humanitarian aid and development, namely, charitable fundraising and financial support services for research in dementia; charitable fundraising for dementia research; charitable fundraising for the purchase of food, clothing and medical items for those in need; financial sponsorship of medical research in the field of dementia; financial management and administration of charitable funds for dementia research; distribution and allocation of charitable funds, namely, accepting and administering monetary charitable contributions to fund medical research; credit card and charge card payment processing services; providing of financial information regarding corporate donations and payroll donations by employees; financial information, advisory, and consultancy services in relation to the aforesaid servicesACTIVE—
042Scientific and technological services, namely, research and design in the field of pharmaceutical development; scientific and technological services, namely, medical research and product development in the field of dementia; industrial analysis and research services in the field of computer hardware; design and development of computer hardware and software; design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; laboratory research in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; laboratory testing services in the field of pharmaceutical product testing; medical research laboratory services; medical research services in relation to the causes, symptoms, diagnosis, treatment and prevention of dementia; scientific genetic research in the field of dementia; provision of scientific research facilities in the nature of laboratories; medical research in relation to medicines and pharmaceuticals; medical research services; design and development of mobile device software applications; design and development of computer programsACTIVE—
044Medical services; the provision of medical information, online via the Internet, on the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; medical services concerning dementia, namely physician, nursing, midwifery and hospital services; diagnostic and laboratory services, namely, medical testing for diagnostic or treatment purposes; hygienic and beauty care for human beings; agricultural services, namely, agricultural advice; dentistry services; medical analysis for the diagnosis and treatment of individuals and groups of people with dementia including x-ray examinations and taking blood samples; pharmaceutical advice; medical clinic services; medical treatment services; medical analysis services; medical information services; nursing services; information, advisory and consultancy services relating to all the aforesaid, including information provided on-line from a computer database, intranets, extranets and the InternetACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 11, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 23, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 23, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 18, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 9, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 23, 2020MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Jun 23, 2020ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Jun 23, 2020EXPTEXPARTE APPEAL TERMINATED—
Apr 1, 2020EXPAEX PARTE APPEAL-REFUSAL AFFIRMED—
Nov 20, 2019GNSNNOTIFICATION OF EXAMINERS STATEMENT E-MAILED—
Nov 20, 2019GNESEXAMINERS STATEMENT E-MAILED—
Nov 20, 2019CNESEXAMINERS STATEMENT - COMPLETED—
Sep 30, 2019JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jul 26, 2019GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Jul 26, 2019GECDACTION DENYING REQ FOR RECON E-MAILED—
Jul 26, 2019CNCFACTION CONTINUING FINAL - COMPLETED—
Jun 25, 2019EXPIEX PARTE APPEAL-INSTITUTED—
Jun 25, 2019JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jun 20, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jun 19, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Jun 19, 2019PGTTPETITION GRANTED - TTAB APPEAL FILED—
Jun 19, 2019APETASSIGNED TO PETITION STAFF—
May 23, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB—
May 21, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2019PROATEAS PETITION TO REVIVE RECEIVED—
May 21, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Mar 21, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 21, 2019MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 21, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 2, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 17, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 17, 2018OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 11, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 5, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 5, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 5, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 3, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 2, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 1, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 9, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2017RFRRREFUSAL PROCESSED BY MPU—
May 29, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 28, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 13, 2017DOCKASSIGNED TO EXAMINER—
May 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance